148 related articles for article (PubMed ID: 11870819)
21. Improving Cox survival analysis with a neural-Bayesian approach.
Bakker B; Heskes T; Neijt J; Kappen B
Stat Med; 2004 Oct; 23(19):2989-3012. PubMed ID: 15351957
[TBL] [Abstract][Full Text] [Related]
22. Bayesian joint modeling of longitudinal measurements and time-to-event data using robust distributions.
Baghfalaki T; Ganjali M; Hashemi R
J Biopharm Stat; 2014; 24(4):834-55. PubMed ID: 24697192
[TBL] [Abstract][Full Text] [Related]
23. A Bayesian approach for inference from a bridging study with binary outcomes.
Gandhi M; Mukherjee B; Biswas D
J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
[TBL] [Abstract][Full Text] [Related]
24. Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials.
Collier W; Haaland B; Inker LA; Heerspink HJL; Greene T
BMC Med Res Methodol; 2024 Feb; 24(1):39. PubMed ID: 38365599
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis for the evaluation of potential surrogate markers.
Daniels MJ; Hughes MD
Stat Med; 1997 Sep; 16(17):1965-82. PubMed ID: 9304767
[TBL] [Abstract][Full Text] [Related]
26. Monte Carlo approaches to frequentist multiplicity-adjusted benefiting subgroup identification.
Schnell PM
Stat Methods Med Res; 2021 Apr; 30(4):1026-1041. PubMed ID: 33256562
[TBL] [Abstract][Full Text] [Related]
27. Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.
Zaslavsky BG
Biometrics; 2013 Mar; 69(1):157-63. PubMed ID: 23002906
[TBL] [Abstract][Full Text] [Related]
28. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
Jiang Z; Song Y; Shou Q; Xia J; Wang W
Trials; 2014 Dec; 15():500. PubMed ID: 25528466
[TBL] [Abstract][Full Text] [Related]
29. A calibrated Bayesian method for the stratified proportional hazards model with missing covariates.
Kim S; Kim JK; Ahn KW
Lifetime Data Anal; 2022 Apr; 28(2):169-193. PubMed ID: 35034213
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkers.
Zhao L; Feng D; Neelon B; Buyse M
Stat Med; 2015 May; 34(10):1733-46. PubMed ID: 25630845
[TBL] [Abstract][Full Text] [Related]
31. Empirical Bayes interval estimates that are conditionally equal to unadjusted confidence intervals or to default prior credibility intervals.
Bickel DR
Stat Appl Genet Mol Biol; 2012 Feb; 11(3):Article 7. PubMed ID: 22499708
[TBL] [Abstract][Full Text] [Related]
32. Bayesian internal dosimetry calculations using Markov Chain Monte Carlo.
Miller G; Martz HF; Little TT; Guilmette R
Radiat Prot Dosimetry; 2002; 98(2):191-8. PubMed ID: 11926369
[TBL] [Abstract][Full Text] [Related]
33. Bayesian estimation of the number of inversions in the history of two chromosomes.
York TL; Durrett R; Nielsen R
J Comput Biol; 2002; 9(6):805-18. PubMed ID: 12614548
[TBL] [Abstract][Full Text] [Related]
34. Bayesian restoration of a hidden Markov chain with applications to DNA sequencing.
Churchill GA; Lazareva B
J Comput Biol; 1999; 6(2):261-77. PubMed ID: 10421527
[TBL] [Abstract][Full Text] [Related]
35. Comparing variational Bayes with Markov chain Monte Carlo for Bayesian computation in neuroimaging.
Nathoo FS; Lesperance ML; Lawson AB; Dean CB
Stat Methods Med Res; 2013 Aug; 22(4):398-423. PubMed ID: 22642986
[TBL] [Abstract][Full Text] [Related]
36. Bayesian versus frequentist hypotheses testing in clinical trials with dichotomous and countable outcomes.
Zaslavsky BG
J Biopharm Stat; 2010 Sep; 20(5):985-97. PubMed ID: 20721786
[TBL] [Abstract][Full Text] [Related]
37. Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models.
Taylor JM; Conlon AS; Elliott MR
Clin Trials; 2015 Aug; 12(4):317-22. PubMed ID: 25490988
[TBL] [Abstract][Full Text] [Related]
38. Fully Bayesian estimation of Gibbs hyperparameters for emission computed tomography data.
Higdon DM; Bowsher JE; Johnson VE; Turkington TG; Gilland DR; Jaszczak RJ
IEEE Trans Med Imaging; 1997 Oct; 16(5):516-26. PubMed ID: 9368107
[TBL] [Abstract][Full Text] [Related]
39. Bayesian semi-parametric ROC analysis.
Erkanli A; Sung M; Costello EJ; Angold A
Stat Med; 2006 Nov; 25(22):3905-28. PubMed ID: 16416403
[TBL] [Abstract][Full Text] [Related]
40. Empirical Bayes models of Poisson clinical trials and sample size determination.
Zaslavsky BG
Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
